US equities |
MU $914.94 ▲+4.26% TSLA $395.52 ▲+6.26% NVDA $216.27 ▲+2.52% SPCX $148.71 ▲+0.83% META $637.26 ▼-0.83% AAPL $343.49 ▼-1.22% SNDK $1,279.82 ▲+3.38% INTC $91.82 ▲+5.59%
FinancialContent

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

9.205 -0.395 (-4.11%)
Delayed Quote Updated: 2:01 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Appoints Greg Ciongoli to Board of Directors
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces 1-for-80 Reverse Stock Split
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio to Present at Cantor Global Healthcare Conference
From Gossamer Bio, Inc.
Via Business Wire
Friday's session: most active stocks ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
News headline image
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
From Gossamer Bio, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase
Via AB Newswire
Topics Artificial Intelligence
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million. ProMIS Neurosciences (NASDAQ:PMN) shares increased... 
Via Benzinga
Top movers in Monday's after hours session ↗
Via Chartmill
Which stocks are moving on Monday? ↗
Via Chartmill
Curious about the most active stocks on Monday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular session. The company's market cap stands at $100.9 million. Gossamer Bio (NASDAQ:GOSS) shares moved... 
Via Benzinga
Monday's session: top gainers and losers ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update
From Gossamer Bio, Inc.
Via Business Wire
Top movers in Monday's after hours session ↗
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
From Gossamer Bio, Inc.
Via Business Wire
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
From Gossamer Bio, Inc.
Via Business Wire
News headline image
CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
From Gossamer Bio, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >